Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Friday, June 19, 2026
🌏 NMPA

Cancer Treatment News

🌏 NMPA

NMPA breaking news and regulatory updates for BD, investors, and analysts

Showing 1–3 of 3 articles

Critical impact NewsApr 24, 2026

CatalYm Doses First Patient in Phase 2/3 Trial of Visugromab for Cancer Cachexia

2 min

Kenji Watanabe
High impact NewsApr 18, 2026

Antengene Presents Three Novel Cancer Programs at AACR 2026: Next-Generation ADC and TCE Therapies Show Promise

2 min

Dr. Priya Sharma
High impact NewsApr 18, 2026

Antengene Presents Next-Generation ADC and AnTenGager TCE Programs at AACR 2026

2 min

Dr. Yuki Tanaka

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.